Search for: "Sepracor Inc."
Results 1 - 20 of 42
Sorted by Relevance | Sort by Date
20 Mar 6:00 am
... : Robert Chapman v Michael Casner (Law360) Prilosec (Omeprazole) - US: Dr Reddy's wins summary judgment of non infringement against AstraZeneca in Prilosec litigation (IP Watchdog)
Renagel (Sevelamer hydrochloride) - US: Genzyme files suit against Impax over Renagel ANDA (Law360) (GenericsWeb) Solodyn (Minocycline) - US: Teva and Medicis announce settlement
agreement relating to Solodyn (SmartBrief) (Law360) Xopenex (Levosalbutamol) - US: Sepracor settles Xopenex suit with Barr (Patent Docs)
16 Mar 8:52 pm
By Suresh Pillai -- Sepracor Settles Xopenex Suit With Barr Last week, Sepracor Inc. and Barr
Pharmaceuticals, Inc. (a Teva Pharmaceuticals subsidiary) entered into a settlement agreement that effectively ends a dispute between the two companies over the patent family
covering Xopenex®, an inhaled asthma treatment. Sepracor's initial complaint against Barr, filed in July of 2007 (see "Court Report," July 22,
2007), alleged infringement of ...
6 Jul 4:37 pm
In re Sepracor Inc. Fair Labor Standards Act (FLSA) Litigation Defendant Sepracor Inc.
(Sepracor) moved, pursuant to 28 U.S.C. § 1407, for coordinated or consolidated pretrial proceedings of this litigation in the Middle District
of Florida or, alternatively, the District of Massachusetts. Plaintiffs in an action pending in the District of Arizona action opposed the [...]
19 Apr, 2007 7:10 am
... any number of times, and justifiably so, but when they get it right, we should take notice of that, as well:"UnitedHealth Group Inc. has cut patient fees as much as 90
percent for an asthma inhaler made by Sepracor Inc. that doesn't use a banned air pollutant."Turns out that Sepracor's Xopenex inhaler is CFC-free, and is apparently just as effective as its CFC-prone competitors. By giving its insureds a specific, easily understood
(and ...
18 Dec, 2008 12:24 am
Lupin Ltd. has reported to settle all patent infringement lawsuits with Schering-Plough Corp. and Sepracor, Inc. relating anti-allergic
drug Clarinex tablets, generically known as desloratadine. Under the terms of the settlement, ... be able to commercialize its generic Clarinex tablets on July 01, 2012 or earlier in
certain circumstances. Earlier in November 2007, Sepracor and University of Massachusetts filed an infringement lawsuit against Lupin for
alleged infringement of the US Patent Nos. 7, ...
23 Dec, 2008 10:02 am
... Dr. Reddy's Laboratories said Dec. 23 it settled a patent dispute with Schering-Plough Corp. and Sepracor Inc. over the allergy drug
Clarinex. Under the settlement, India-based Dr. Reddy's will be able to sell generic versions Clarinex-D 12 Hour, Clarinex-D 24 Hour, and ... infringement actions filed by Kenilworth,
N.J.-based Schering-Plough and Marlborough, Mass.-based Sepracor against Dr. Reddy's in U.S. District Court for the District of New Jersey.
Specific terms of ...
27 Oct 1:40 pm
... FDA-approved label for a prescription medication often comes up short as regards the drug's efficacy, or benefits: In the case of Sepracor
Inc.'s blockbuster sleeping pill Lunesta, it's virtually impossible to tell how well the drug works based on ... alertness," the authors state. Despite that lackluster finding,
the drug has grown into a $600 million-a-year drug for Sepracor, helped by the company's advertisements featuring a green Lunesta moth. Next,
Perrone's October 21 AP article shows how ...
2 Nov 9:34 am
... nine Massachusetts companies with training and employment services. Impacted workers , who lost their jobs between November 2008 and October 2009, are from ACT Electronics
Inc., Altus Pharmaceuticals Inc., Bose Corp., DHL, EMC Corp., Sepracor Inc., Snap-on Inc., Staples Inc. and
Taylor Corp., in information, manufacturing, retail and transportation industries. The grant was awarded to the Massachusetts Department of Workforce Development ...
6 Apr, 2008 7:25 pm
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic
monitoring. Sepracor Inc. et al. v. Sandoz, Inc. 3:08-cv-01584; filed March 31, 2008 in the District Court of Delaware
Infringement...
20 Apr, 2008 8:40 pm
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic
monitoring. Sepracor Inc. et al. v. Synthon Pharmaceuticals, Inc. et al. 5:08-cv-00179; filed April 11, 2008 in the Eastern
District...
16 Jun, 2008 4:46 am
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic
monitoring. Sepracor Inc. et al. v. Sandoz, Inc. 4:08-cv-00089; filed June 12, 2008 in the Eastern District of North Carolina
Infringement of U.S. Patent No. 5,698,558 ("Methods for Treating Allergic Disorders Using Optically Pure (-)Cetirizine," ...
4 Aug, 2008 12:25 am
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic
monitoring. Sepracor Inc. et al. v. Barr Pharmaceuticals, Inc. et al. 5:08-cv-00362; filed July 30, 2008 in the Eastern District
of North Carolina Infringement of U.S. Patent No. 5,698,558 ("Methods for Treating Allergic Disorders Using ...
11 Aug, 2008 3:40 am
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic
monitoring. Sepracor Inc. et al. v. Barr Pharmaceuticals, Inc. et al. 3:08-cv-03920; filed August 4, 2008 in the District Court
of New Jersey Infringement of U.S. Patent No. 5,698,558 ("Methods for Treating Allergic Disorders Using ...
28 Sep, 2008 8:48 pm
... -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring.
Sepracor Inc. and University of Massachusetts v. Pharmaceutical Associates, Inc.3:08-cv-04718; filed September 19. 2008 in the
District Court of New Jersey Infringement of U.S. Patent Nos. 7,214,683 ("Compositions of Descarboethoxyloratadine," issued ...
22 Jun 8:57 pm
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic
monitoring. Sepracor Inc. et al. v. Synthon Pharmaceuticals, Inc. et al. 5:09-cv-00264; filed June 17, 2009 in the Eastern
District of North Carolina Infringement of U.S. Patent No. 5,698,558 ("Methods for Treating Allergic Disorders Using ...
26 Mar, 2007 8:41 pm
By Sherri Oslick --- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic
monitoring. Dey, L.P. et. al. v. Sepracor, Inc.1:07-cv-02353; filed March 21, 2007 in the Southern District of New York Declaratory...
9 Sep, 2007 9:29 pm
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic
monitoring. Sepracor Inc. et al. v. Sun Pharmaceutical Industries Ltd.3:07-cv-04213; filed September 4, 2007 in the District Court of
New...
22 Oct, 2007 8:59 pm
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic
monitoring. Sepracor Inc. et al. v. Dr. Reddy's Laboratories, Ltd. et al. 3:07-cv-05001; filed October 17, 2007 in the District...
20 Feb 1:00 am
... fraud arising from counsel's omissions in patent application process: Kaiser Foundation Health Plan, Inc v Abbott Laboratories, Inc (Intellectual Property Law Blog)
Januvia (Sitagliptin) - Netherlands: Closer reading shows Netherland Patent Office ... (Eszopiclone) - US: Teva and Cobalt file applications to produce generic versions of
Sepracor's Lunestra, alleging invalidity/unenforceability of Sepracor patent (GenericsWeb) Opana
(Oxymorphone) - US: Endo, Penwest reach settlement with Actavis in ...
15 Oct, 2007 10:19 am
... s own convenience and protection as a way of putting stumbling-blocks before patent applicants. Teva Pharmaceutical Industries Ltd and another v Merrell Pharmaceuticals Inc,
Aventis and Sepracor [2007] EWHC 2276 (Ch) was a Patents Court decision of Mr Justice Warren last ... generic name fexofenadine which, when
taken, produced an acid metabolite inside the human body. Aventis and Sepracor owned two other patents which related to the use of the acid
metabolite itself, rather than ...
Search on: Blawgs.FM | BlawgSearch Google Co-op | Blawg.com | Bloglines | Feedster | Google Blog Search | Technorati | Google | MSN | Yahoo!